Raiffeisen Bank International AG Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Raiffeisen Bank International AG bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,172 shares of the biotechnology company’s stock, valued at approximately $1,917,000.

Several other large investors also recently modified their holdings of the stock. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the fourth quarter valued at $40,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise during the 4th quarter worth $45,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth $53,000. GPS Wealth Strategies Group LLC increased its holdings in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after acquiring an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at about $59,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 9,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the transaction, the president now owns 308,714 shares of the company’s stock, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,764 shares of company stock valued at $14,856,635. Corporate insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of several recent research reports. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a report on Thursday, May 8th. Barclays increased their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $652.73.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $733.18 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $735.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market cap of $57.08 billion, a P/E ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The firm’s fifty day moving average price is $584.61 and its 200-day moving average price is $593.44.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter last year, the business posted $1.15 earnings per share. The company’s revenue for the quarter was up 31.3% on a year-over-year basis. On average, equities research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.